628.55
-0.09%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Solara Active Pharma has gained 23.46% in the last 1 Week
More from Solara Active Pharma Sciences Ltd.
Recommended